Literature DB >> 33527116

Needed: A Life Course Perspective on Maintaining Pre-exposure Prophylaxis Use.

Aaron J Siegler1.   

Abstract

Entities:  

Keywords:  HIV; PrEP; pre-exposure prophylaxis; retention

Mesh：

Substances：

Year:  2021        PMID： 33527116      PMCID： PMC7850543          DOI： 10.1093/cid/ciaa040

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  18 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

3.  Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

4.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Authors:  Patrick S Sullivan; Robertino Mera Giler; Farah Mouhanna; Elizabeth S Pembleton; Jodie L Guest; Jeb Jones; Amanda D Castel; Howa Yeung; Michael Kramer; Scott McCallister; Aaron J Siegler
Journal:  Ann Epidemiol       Date:  2018-06-22       Impact factor: 3.797

5.  Pre-exposure Prophylaxis Uptake and Discontinuation Among Young Black Men Who Have Sex With Men in Atlanta, Georgia: A Prospective Cohort Study.

Authors:  David P Serota; Eli S Rosenberg; Patrick S Sullivan; Annie L Thorne; Charlotte-Paige M Rolle; Carlos Del Rio; Scott Cutro; Nicole Luisi; Aaron J Siegler; Travis H Sanchez; Colleen F Kelley
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

6.  Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.

Authors:  Philip A Chan; Leandro Mena; Rupa Patel; Catherine E Oldenburg; Laura Beauchamps; Amaya G Perez-Brumer; Sharon Parker; Kenneth H Mayer; Matthew J Mimiaga; Amy Nunn
Journal:  J Int AIDS Soc       Date:  2016-06-13       Impact factor: 5.396

7.  Developing a Web-Based Geolocated Directory of HIV Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator Protocol and Operating Procedures.

Authors:  Aaron J Siegler; Susan Wirtz; Shannon Weber; Patrick S Sullivan
Journal:  JMIR Public Health Surveill       Date:  2017-09-06

8.  Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi.

Authors:  Trisha Arnold; Lauren Brinkley-Rubinstein; Philip A Chan; Amaya Perez-Brumer; Estefany S Bologna; Laura Beauchamps; Kendra Johnson; Leandro Mena; Amy Nunn
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

9.  Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.

Authors:  Kelsey C Coy; Ronald J Hazen; Heather S Kirkham; Ambrose Delpino; Aaron J Siegler
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

10.  Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care.

Authors:  Douglas Krakower; Kevin M Maloney; Victoria E Powell; Ken Levine; Chris Grasso; Kathy Melbourne; Julia L Marcus; Kenneth H Mayer
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396
View more
  1 in total

1.  Predictors of Re-Initiation of Daily Oral Preexposure Prophylaxis Regimen After Discontinuation.

Authors:  Casey D Xavier Hall; Michael E Newcomb; Christina Dyar; Brian Mustanski
Journal:  AIDS Behav       Date:  2022-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.